News & Legal Notices
Posted on January 24, 2022
Q2 2022 Update to Injectable Medication/Specialty Pharmacy Fee Schedule
Posted on January 23, 2022
FDA Warning: Severe Dental Problems with Pain Medicine Buprenorphine
Posted on January 19, 2022
Quarterly Claim Editing Update: First Quarter 2022
Posted on January 17, 2022
Nitroglycerin Lingual Spray Recalled Due to a Possible Defective Delivery System
Posted on January 17, 2022
Metformin Extended-Release Tablets, USP 750 mg, Recalled
Posted on January 17, 2022
January 2022 Cardiac and Orthopedic Code Updates: Surgical and Implantable Device Management Program
Posted on January 14, 2022
NYC Medicare Advantage Plus Plan Update
Posted on January 11, 2022
Reimbursement Rates for 2022 Procedure Codes
Posted on January 3, 2022
Program Implementation Delayed: TurningPoint Surgical and Implantable Device Management Program for Spine Services
Posted on December 29, 2021